Nexgel Change In Cash from 2010 to 2024

NXGL Stock  USD 3.56  0.15  4.40%   
Nexgel Change In Cash yearly trend continues to be quite stable with very little volatility. Change In Cash may rise above about 1.7 M this year. From the period between 2010 and 2024, Nexgel, Change In Cash regression line of its data series had standard deviation of  4,863,379 and standard deviation of  4,863,379. View All Fundamentals
 
Change In Cash  
First Reported
2017-12-31
Previous Quarter
-1.4 M
Current Value
-10 K
Quarterly Volatility
2.9 M
 
Covid
Check Nexgel financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nexgel's main balance sheet or income statement drivers, such as Depreciation And Amortization of 266.2 K, Total Revenue of 2.1 M or Gross Profit of 650 K, as well as many indicators such as Price To Sales Ratio of 2.81, Dividend Yield of 0.0 or PTB Ratio of 2.44. Nexgel financial statements analysis is a perfect complement when working with Nexgel Valuation or Volatility modules.
  
Check out the analysis of Nexgel Correlation against competitors.

Latest Nexgel's Change In Cash Growth Pattern

Below is the plot of the Change In Cash of Nexgel Inc over the last few years. It is Nexgel's Change In Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nexgel's overall financial position and show how it may be relating to other accounts over time.
Change In Cash10 Years Trend
Very volatile
   Change In Cash   
       Timeline  

Nexgel Change In Cash Regression Statistics

Arithmetic Mean1,061,730
Geometric Mean1,431,741
Coefficient Of Variation458.06
Mean Deviation2,090,656
Median1,317,000
Standard Deviation4,863,379
Sample Variance23.7T
Range25.6M
R-Value(0.07)
Mean Square Error25.3T
R-Squared0.01
Significance0.80
Slope(79,012)
Total Sum of Squares331.1T

Nexgel Change In Cash History

20241.7 M
20231.6 M
2022-12.2 M
202113.3 M
2020-229 K
2019261 K
20181.5 M

About Nexgel Financial Statements

Nexgel investors utilize fundamental indicators, such as Change In Cash, to predict how Nexgel Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Change In Cash1.6 M1.7 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Nexgel Inc is a strong investment it is important to analyze Nexgel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nexgel's future performance. For an informed investment choice regarding Nexgel Stock, refer to the following important reports:
Check out the analysis of Nexgel Correlation against competitors.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexgel. If investors know Nexgel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexgel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.59)
Revenue Per Share
0.846
Quarterly Revenue Growth
0.234
Return On Assets
(0.23)
Return On Equity
(0.64)
The market value of Nexgel Inc is measured differently than its book value, which is the value of Nexgel that is recorded on the company's balance sheet. Investors also form their own opinion of Nexgel's value that differs from its market value or its book value, called intrinsic value, which is Nexgel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexgel's market value can be influenced by many factors that don't directly affect Nexgel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexgel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexgel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexgel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.